Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-04 @ 6:49 PM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006252
Protocol Section: NCT00006252
Start Identification Module Data
Brief Title: Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma
Official Title: Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Low-Grade Non-Hodgkins Lymphoma and Mantle Cell Lymphoma With Allogeneic Donor Stem Cells
Acronym: None
Organization: Alliance for Clinical Trials in Oncology
Organization Class: OTHER
Organization Study ID: CALGB-109901
Secondary IDs
Secondary ID Type Domain Link
CALGB-109901 None None None
U10CA031946 NIH None None
CDR0000068185 REGISTRY NCI Physician Data Query httpsreporternihgovquickSearchU10CA031946
Start Status Module Data
Status Verified Date: 2016-07
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Cancer and Leukemia Group B
Lead Sponsor Class: NETWORK
Lead Sponsor: Cancer and Leukemia Group B
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload